### 17542 Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices

Washington, DC 20423–0001. In addition, a copy of each pleading must be served on applicant’s representative, Roger A. Serpe, General Counsel, Indiana Harbor Belt Railroad Company, 55 W. Monroe Street Suite 1600, Chicago, IL 60603.

Board decisions and notices are available on our Web site at

‘‘ WWW.STB.DOT.GOV.’’

Decided: March 27, 2015. By the Board, Rachel D. Campbell, Director, Office of Proceedings. Jeffrey Herzig, Clearance Clerk. [FR Doc. 2015–07560 Filed 3–31–15; 8:45 am]
**BILLING CODE 4915–01–P**

**DEPARTMENT OF TRANSPORTATION**
**Federal Aviation Administration First Meeting: RTCA Special**  **Committee 234, Portable Electronic Devices (PEDs)** 

**AGENCY :**  Federal Aviation Administration (FAA), U.S. Department of Transportation (DOT). **ACTION :**  Meeting notice of RTCA Special Committee 234, Portable Electronic Devices (PEDs).

**SUMMARY :**  The FAA is issuing this notice to advise the public of the first meeting of the RTCA Special Committee 234, Portable Electronic Devices (PEDs). **DATES :**  The meeting will be held May 6th to 7th, 2015 from 9:00 a.m.–5:00 p.m. **ADDRESSES :**  RTCA Inc., 1150 18th Street NW., Suite 910, Washington, DC 200036.
**FOR FURTHER INFORMATION CONTACT :**  The RTCA Secretariat, 1150 18th Street NW., Suite 910, Washington, DC 20036, or by telephone at (202) 330–0652/(202) 833– 9339, fax at (202) 833–9434, or Web site at http://www.rtca.org. Additional contact information: RTCA contact is Karan Hofmann, khofmann@rtca.org, (202) 330–0680. **SUPPLEMENTARY INFORMATION :**  Pursuant to section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92– 463, 5 U.S.C., App.), notice is hereby given for a meeting of Special Committee 234. The agenda will include the following: Wednesday May 6th

• Welcome

• Administrative Remarks

• Introductions

• Agenda Review

• RTCA Overview Presentation

• SC–234 Scope and Terms of Reference

review • WG–99 Progress Presentation

• Presentation on PED ARC Outcome

• SC–234/WG–99 Structure and

Organization of Work

• Proposed Schedule

• RTCA workspace presentation

• Other Business

• Date and Place of Next Meeting

• Adjourn Thursday, May 7th

• Continuation of Plenary or Working

Group Session Attendance is open to the interested public but limited to space availability. With the approval of the chairman, members of the public may present oral statements at the meeting. Persons wishing to present statements or obtain information should contact the person listed in the **FOR FURTHER INFORMATION CONTACT**  section. Members of the public may present a written statement to the committee at any time.

Issued in Washington, DC, on March 27, 2015. Mohannad Dawoud, Management Analyst, NextGen, Program Oversight and Administration, Federal Aviation Administration. [FR Doc. 2015–07511 Filed 3–31–15; 8:45 am]
**BILLING CODE 4910–13–P**

**DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety**  **Administration [Docket No. FMCSA–2014–0216]**  **Qualification of Drivers; Exemption Applications; Epilepsy and Seizure**  **Disorders**

**AGENCY :**  Federal Motor Carrier Safety Administration (FMCSA), DOT. **ACTION :**  Notice of final disposition.

**SUMMARY :**  FMCSA announces its decision to grant requests from 6 individuals for exemptions from the regulatory requirement that interstate commercial motor vehicle (CMV) drivers have ‘‘no established medical history or clinical diagnosis of epilepsy or any other condition which is likely to cause loss of consciousness or any loss of ability to control a CMV.’’ The regulation and the associated advisory criteria published in the Code of Federal Regulations as the ‘‘Instructions for Performing and Recording Physical Examinations’’ have resulted in numerous drivers being prohibited from operating CMVs in interstate commerce based on the fact that they have had oneor more seizures and are taking antiseizure medication, rather than an individual analysis of their circumstances by a qualified medical examiner. The Agency concluded that granting exemptions for these CMV drivers will provide a level of safety that is equivalent to or greater than the level of safety maintained without the exemptions. FMCSA grants exemptions that will allow these 6 individuals to operate CMVs in interstate commerce for a 2-year period. The exemptions preempt State laws and regulations and may be renewed. **DATES :**  The exemptions are effective April 1, 2015. The exemptions expire on April 1, 2017. **FOR FURTHER INFORMATION CONTACT :**  Charles A. Horan, III, Director, Office of Carrier, Driver and Vehicle Safety, (202) 366–4001, fmcsamedical@dot.gov, FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64–224, Washington, DC 20590–0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. **SUPPLEMENTARY INFORMATION :**  A. Electronic Access

You may see all the comments online through the Federal Document Management System (FDMS) at: http:// www.regulations.gov

.

Docket: For access to the docket to read background documents or comments, go to http:// www.regulations.gov and/or Room W12–140 on the ground level of the West Building, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal holidays.

Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL–14 FDMS), which can be reviewed at www.dot.gov/privacy

. B. Background

Under 49 U.S.C. 31136(e) and 31315(b), FMCSA may grant an exemption from the safety regulations for a 2-year period if it finds ‘‘such exemption would likely achieve a level of safety that is equivalent to or greater than the level that would be achieved absent such exemption.’’ The statute also allows the Agency to renew exemptions at the end of the 2-year period.

FMCSA grants 6 individuals an exemption from the regulatory requirement in§ 391.41(b)(8), to allow these individuals who take anti-seizure